1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Diagnosis distribution for positive control subjects
PC Diagnosis PC Definite (No.) (%) PC Indeterminate (No.) (%) PC Total (No.) (%) Nonspecific (vascular, migraine) 20 (77) 9 (90) 29 (81) Ischemic/cerebrovascular 1 (4) 0 1 (3) Tumor 2 (8) 2 (20) 4 (11) Leukoencephalopathy/diffuse WM disease 2 (8) 0 2 (6) Possible demyelinating 0 10 (100) 10 (28) Other inflammatory 8 (31) 1 (10) 9 (25)